Balance Sheet
Cash Flow Statement
Amortizatization of IntangiblesCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in CashChange in Interest ReceivablesChange in Net LoansChange in ReceivablesDepreciation & Amortization (CF)Depreciation and DepletionFree Cash FlowGains from Investment SecuritiesGains from Sales and DivestituresLong-Term Debt RepaymentsNet Cash FlowNet IncomeNon-cash ItemsOther financing activitiesShare-based CompensationShares IssuedShort-Term Debt issuances
Daily Values
Growth Metrics
Income Statement
Others
Ratios

iBio (IBIO) Short-Term Debt issuances (2023 - 2025)

iBio (IBIO) has disclosed Short-Term Debt issuances for 3 consecutive years, with $105000.0 as the latest value for Q3 2025.

  • On a quarterly basis, Short-Term Debt issuances changed N/A to $105000.0 in Q3 2025 year-over-year; TTM through Sep 2025 was $105000.0, a N/A change, with the full-year FY2024 number at $204000.0, changed N/A from a year prior.
  • Short-Term Debt issuances was $105000.0 for Q3 2025 at iBio, up from -$691000.0 in the prior quarter.
  • In the past five years, Short-Term Debt issuances ranged from a high of $691000.0 in Q1 2024 to a low of -$691000.0 in Q2 2024.
  • A 3-year average of $77250.0 and a median of $154500.0 in 2023 define the central range for Short-Term Debt issuances.